Nicole Lambert - 31 Oct 2023 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role: Chief Operating Officer
Signature: By: Justin Hunter For: Nicole Lambert
Issuer symbol: MYGN
Transactions as of: 31 Oct 2023
Net transactions value: $0
Form type: 4
Filing time: 01 Nov 2023, 16:13:01 UTC
Previous filing: 10 Oct 2023
Next filing: 07 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MYGN	Common Stock						223,993	31 Oct 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Nicole Lambert is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

This "Exit" Form 4 is voluntarily filed to report solely that the Reporting Person is no longer serving in the role as the Company's Chief Operating Officer, effective October 31, 2023, and therefore is no longer subject to Section 16 reporting.